The FDA employs a variety of epidemiological tools to ensure drug safety, including randomized controlled trials (RCTs), cohort studies, and meta-analyses. They also conduct pharmacovigilance activities to monitor drugs post-market, ensuring any adverse effects are promptly identified and addressed.